Advertisement

Breast Cancer Pain: A Review of Pathology and Interventional Techniques

  • Ali Valimahomed
  • Jennifer Zocca
  • Amitabh Gulati
Chapter

Abstract

Postmastectomy pain syndromes (PMPS) are a significant burden for breast cancer patients. Many of the pain syndromes are associated with the treatment of disease, chemotherapy, surgery, and radiation. Because of the musculoskeletal and neurologic complexities of the anterior chest wall, often the source of pain is difficult to determine and treat. We discuss the various musculoskeletal and neurologic pain sequelae that a breast cancer patient may exhibit. Given the various treatment options that are available for our patients, we develop a therapeutic approach to address a patient’s pain syndromes.

Keywords

Breast cancer pain Postmastectomy pain syndrome Myofascial pain syndrome Shoulder pain Serratus anterior plane block 

References

  1. 1.
    Glare PA, Davies PS, Finlay E, et al. Pain in cancer survivors. J Clin Oncol. 2014;32(16):1739–47.  https://doi.org/10.1200/JCO.2013.52.4629.PubMedPubMedCentralCrossRefGoogle Scholar
  2. 2.
    Pachman DR, Barton DL, Swetz KM, Loprinzi CL. Troublesome symptoms in cancer survivors: fatigue, insomnia, neuropathy, and pain. J Clin Oncol. 2012;30(30):3687–96.  https://doi.org/10.1200/JCO.2012.41.7238.PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
    van den Beuken-van Everdingen MHJ, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007;18(9):1437–49.  https://doi.org/10.1093/annonc/mdm056.PubMedCrossRefGoogle Scholar
  4. 4.
    Peuckmann V, Ekholm O, Rasmussen NK, et al. Chronic pain and other sequelae in long-term breast cancer survivors: nationwide survey in Denmark. Eur J Pain. 2009;13(5):478–85.  https://doi.org/10.1016/j.ejpain.2008.05.015.PubMedCrossRefGoogle Scholar
  5. 5.
    Hofsø K, Rustøen T, Cooper BA, Bjordal K, Miaskowski C. Changes over time in occurrence, severity, and distress of common symptoms during and after radiation therapy for breast Cancer. J Pain Symptom Manag. 2013;45(6):980–1006.  https://doi.org/10.1016/j.jpainsymman.2012.06.003.CrossRefGoogle Scholar
  6. 6.
    Ebaugh D, Spinelli B, Schmitz KH. Shoulder impairments and their association with symptomatic rotator cuff disease in breast cancer survivors. Med Hypotheses. 2011;77(4):481–7.  https://doi.org/10.1016/j.mehy.2011.06.015.PubMedCrossRefGoogle Scholar
  7. 7.
    Ewertz M, Jensen AB. Late effects of breast cancer treatment and potentials for rehabilitation. Acta Oncol. 2011;50(2):187–93.  https://doi.org/10.3109/0284186X.2010.533190.PubMedCrossRefGoogle Scholar
  8. 8.
    Gärtner R, Jensen M-B, Nielsen J, Ewertz M, Kroman N, Kehlet H. Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA. 2009;302(18):1985–92.  https://doi.org/10.1001/jama.2009.1568.PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Von Roenn JH, Cleeland CS, Gonin R, Hatfield AK, Pandya KJ. Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med. 1993;119(2):121–6.CrossRefGoogle Scholar
  10. 10.
    de Boer AGEM, Taskila T, Ojajärvi A, van Dijk FJH, Verbeek JHAM. Cancer survivors and unemployment: a meta-analysis and meta-regression. JAMA. 2009;301(7):753–62.  https://doi.org/10.1001/jama.2009.187.PubMedCrossRefGoogle Scholar
  11. 11.
    Tevaarwerk AJ, Lee JW, Sesto ME, et al. Employment outcomes among survivors of common cancers: the Symptom Outcomes and Practice Patterns (SOAPP) study. J Cancer Surviv. 2013;7(2):191–202.  https://doi.org/10.1007/s11764-012-0258-2.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Howlader N, Noone AM, Krapcho M, et al. Surveillance, Epidemiology, and End Results (SEER) cancer statistics review. http://seer.cancer.gov/csr/1975_2012/. Published April 2015. Accessed 6 Nov 2015.
  13. 13.
    Netter FH. Atlas of human anatomy. Philadelphia: Elsevier Health Sciences; 2010.Google Scholar
  14. 14.
    Snell RS. Clinical anatomy by regions. Philadelphia: Lippincott Williams & Wilkins; 2011.Google Scholar
  15. 15.
    Moore KL, Dalley AF, Agur AMR. Clinically oriented anatomy. Philadelphia: Lippincott Williams & Wilkins; 2013.Google Scholar
  16. 16.
    Agur AMR, Dalley AF, Grant JCB. Grant’s atlas of anatomy. Philadelphia: Lippincott Williams & Wilkins; 2013.Google Scholar
  17. 17.
    Deer TR, Leong MS, Gordin V. Treatment of chronic pain by medical approaches: the AMERICAN ACADEMY of PAIN MEDICINE textbook on patient management. New York: Springer; 2014.Google Scholar
  18. 18.
    Warrier S, Hwang S, Koh CE, et al. Preservation or division of the intercostobrachial nerve in axillary dissection for breast cancer: meta-analysis of randomised controlled trials. Breast. 2014;23(4):310–6.  https://doi.org/10.1016/j.breast.2014.01.014.PubMedCrossRefGoogle Scholar
  19. 19.
    Wijayasinghe N, Andersen KG, Kehlet H. Neural blockade for persistent pain after breast cancer surgery. Reg Anesth Pain Med. 2014;39(4):272–8.  https://doi.org/10.1097/AAP.0000000000000101.PubMedCrossRefGoogle Scholar
  20. 20.
    Torres Lacomba M, Mayoral del Moral O, Coperias Zazo JL, Gerwin RD, Goñí AZ. Incidence of myofascial pain syndrome in breast cancer surgery: a prospective study. Clin J Pain. 2010;26(4):320–5.  https://doi.org/10.1097/AJP.0b013e3181c4904a.PubMedCrossRefGoogle Scholar
  21. 21.
    Caban ME, Yadav R. Rehabilitation of breast cancer–related functional deficits. Crit Rev Phys Rehabil Med. 2008;20(1):1–23.CrossRefGoogle Scholar
  22. 22.
    Lavelle ED, Lavelle W, Smith HS. Myofascial trigger points. Med Clin North Am. 2007;91(2):229–39.  https://doi.org/10.1016/j.mcna.2006.12.004.PubMedCrossRefGoogle Scholar
  23. 23.
    Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009;10(9):895–926.  https://doi.org/10.1016/j.jpain.2009.06.012.PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Shin HJ, Shin JC, Kim WS, Chang WH, Lee SC. Application of ultrasound-guided trigger point injection for myofascial trigger points in the subscapularis and pectoralis muscles to post-mastectomy patients: a pilot study. Yonsei Med J. 2014;55(3):792–8.  https://doi.org/10.3349/ymj.2014.55.3.792.PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Proulx AM, Zryd TW. Costochondritis: diagnosis and treatment. Am Fam Physician. 2009;80(6):617–20.PubMedGoogle Scholar
  26. 26.
    Kamel M, Kotob H. Ultrasonographic assessment of local steroid injection in Tietze’s syndrome. Rheumatology. 1997;36(5):547–50.  https://doi.org/10.1093/rheumatology/36.5.547.CrossRefGoogle Scholar
  27. 27.
    Coleman RE, Bolten WW, Lansdown M, et al. Aromatase inhibitor-induced arthralgia: clinical experience and treatment recommendations. Cancer Treat Rev. 2008;34(3):275–82.  https://doi.org/10.1016/j.ctrv.2007.10.004.PubMedCrossRefGoogle Scholar
  28. 28.
    Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12(20 Pt 2):6243s–9s.  https://doi.org/10.1158/1078-0432.CCR-06-0931.PubMedCrossRefGoogle Scholar
  29. 29.
    Smith HS, Barkin RL. Painful boney metastases. Am J Ther. 2014;21(2):106–30.  https://doi.org/10.1097/MJT.0b013e3182456dff.PubMedCrossRefGoogle Scholar
  30. 30.
    Wallace AN, Robinson CG, Meyer J, et al. The metastatic spine disease multidisciplinary working group algorithms. Oncologist. 2015;20(10):1205–15.  https://doi.org/10.1634/theoncologist.2015-0085.PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Greenwood TJ, Wallace A, Friedman MV, Hillen TJ, Robinson CG, Jennings JW. Combined ablation and radiation therapy of spinal metastases: a novel multimodality treatment approach. Pain Physician. 2015;18(6):573–81.PubMedGoogle Scholar
  32. 32.
    Wallace AN, Tomasian A, Vaswani D, Vyhmeister R, Chang RO, Jennings JW. Radiographic local control of spinal metastases with percutaneous radiofrequency ablation and vertebral augmentation. AJNR Am J Neuroradiol. 2016;37(4):759–65.  https://doi.org/10.3174/ajnr.A4595.PubMedCrossRefGoogle Scholar
  33. 33.
    Tasmuth T, Smitten von K, Hietanen P, Kataja M, Kalso E. Pain and other symptoms after different treatment modalities of breast cancer. Ann Oncol. 1995;6(5):453–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Vadivelu N, Schreck M, Lopez J, Kodumudi G, Narayan D. Pain after mastectomy and breast reconstruction. Am Surg. 2008;74(4):285–96.PubMedGoogle Scholar
  35. 35.
    Tasmuth T, Blomqvist C, Kalso E. Chronic post-treatment symptoms in patients with breast cancer operated in different surgical units. Eur J Surg Oncol. 1999;25(1):38–43.  https://doi.org/10.1053/ejso.1998.0597.PubMedCrossRefGoogle Scholar
  36. 36.
    Wallace MS, Wallace AM, Lee J, Dobke MK. Pain after breast surgery: a survey of 282 women. Pain. 1996;66(2–3):195–205.PubMedPubMedCentralCrossRefGoogle Scholar
  37. 37.
    Jung BF, Ahrendt GM, Oaklander AL, Dworkin RH. Neuropathic pain following breast cancer surgery: proposed classification and research update. Pain. 2003;104(1):1–13.  https://doi.org/10.1016/S0304-3959(03)00241-0.PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Figus A, Mazzocchi M, Dessy LA, Curinga G, Scuderi N. Treatment of muscular contraction deformities with botulinum toxin type A after latissimus dorsi flap and sub-pectoral implant breast reconstruction. J Plast Reconstr Aesthet Surg. 2009;62(7):869–75.  https://doi.org/10.1016/j.bjps.2007.07.025.PubMedCrossRefGoogle Scholar
  39. 39.
    Ho JO, Sawadkar P, Mudera V. A review on the use of cell therapy in the treatment of tendon disease and injuries. J Tissue Eng. 2014;5(0):2041731414549678–18.  https://doi.org/10.1177/2041731414549678.PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Desmeules F, Boudreault J, Roy J-S, Dionne C, Frémont P, MacDermid JC. The efficacy of therapeutic ultrasound for rotator cuff tendinopathy: a systematic review and meta-analysis. Phys Ther Sport. 2015;16(3):1–9.  https://doi.org/10.1016/j.ptsp.2014.09.004.CrossRefGoogle Scholar
  41. 41.
    Factor D, Dale B. Current concepts of rotator cuff tendinopathy. Int J Sports Phys Ther. 2014;9(2):274–88.PubMedPubMedCentralGoogle Scholar
  42. 42.
    Fukuda H. Partial-thickness rotator cuff tears: a modern view on Codman’s classic. J Shoulder Elb Surg. 2000;9(2):163–8.  https://doi.org/10.1067/mse.2000.101959.CrossRefGoogle Scholar
  43. 43.
    Teunis T, Lubberts B, Reilly BT, Ring D. A systematic review and pooled analysis of the prevalence of rotator cuff disease with increasing age. J Shoulder Elb Surg. 2014;23(12):1913–21.  https://doi.org/10.1016/j.jse.2014.08.001.CrossRefGoogle Scholar
  44. 44.
    Petrek JA, Heelan MC. Incidence of breast carcinoma-related lymphedema. Cancer. 1998;83(12 Suppl American):2776–81.PubMedCrossRefGoogle Scholar
  45. 45.
    Levy O, Relwani J, Zaman T, Even T, Venkateswaran B, Copeland S. Measurement of blood flow in the rotator cuff using laser Doppler flowmetry. J Bone Joint Surg Br. 2008;90(7):893–8.  https://doi.org/10.1302/0301-620X.90B7.19918.PubMedCrossRefGoogle Scholar
  46. 46.
    Brukner P, Khan K. Brukner & Khan’s clinical sports medicine. Sydney: McGraw-Hill Education; 2011.Google Scholar
  47. 47.
    Lee TS, Kilbreath SL, Refshauge KM, Herbert RD, Beith JM. Prognosis of the upper limb following surgery and radiation for breast cancer. Breast Cancer Res Treat. 2007;110(1):19–37.  https://doi.org/10.1007/s10549-007-9710-9.PubMedCrossRefGoogle Scholar
  48. 48.
    Buckup K. Clinical tests for the musculoskeletal system. Stuttgart: Thieme; 2011.Google Scholar
  49. 49.
    Ardic F, Kahraman Y, Kacar M, Kahraman MC, Findikoglu G, Yorgancioglu ZR. Shoulder impingement syndrome: relationships between clinical, functional, and radiologic findings. Am J Phys Med Rehabil. 2006;85(1):53–60.PubMedCrossRefGoogle Scholar
  50. 50.
    Reilly P, Macleod I, Macfarlane R, Windley J, Emery R. Dead men and radiologists don’t lie: a review of cadaveric and radiological studies of rotator cuff tear prevalence. Ann R Coll Surg Engl. 2006;88(2):116–21.  https://doi.org/10.1308/003588406X94968.PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Ahmed RL, Prizment A, Lazovich D, Schmitz KH, Folsom AR. Lymphedema and quality of life in breast cancer survivors: the Iowa Women’s Health Study. J Clin Oncol. 2008;26(35):5689–96.  https://doi.org/10.1200/JCO.2008.16.4731.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Taghian NR, Miller CL, Jammallo LS, O’Toole J, Skolny MN. Lymphedema following breast cancer treatment and impact on quality of life: a review. Crit Rev Oncol Hematol. 2014;92(3):227–34.  https://doi.org/10.1016/j.critrevonc.2014.06.004.PubMedCrossRefGoogle Scholar
  53. 53.
    Herrera JE, Stubblefield MD. Rotator cuff tendonitis in lymphedema: a retrospective case series. Arch Phys Med Rehabil. 2004;85(12):1939–42.  https://doi.org/10.1016/j.apmr.2004.06.065.PubMedCrossRefGoogle Scholar
  54. 54.
    Shamley DR, Srinanaganathan R, Weatherall R, et al. Changes in shoulder muscle size and activity following treatment for breast cancer. Breast Cancer Res Treat. 2007;106(1):19–27.  https://doi.org/10.1007/s10549-006-9466-7.PubMedCrossRefGoogle Scholar
  55. 55.
    Stubblefield MD, Keole N. Upper body pain and functional disorders in patients with breast cancer. PMR. 2014;6(2):170–83.  https://doi.org/10.1016/j.pmrj.2013.08.605.CrossRefGoogle Scholar
  56. 56.
    Rostkowska E, Bak M, Samborski W. Body posture in women after mastectomy and its changes as a result of rehabilitation. Adv Med Sci. 2006;51:287–97.PubMedGoogle Scholar
  57. 57.
    Crosbie J, Kilbreath SL, Dylke E, et al. Effects of mastectomy on shoulder and spinal kinematics during bilateral upper-limb movement. Phys Ther. 2010;90(5):679–92.  https://doi.org/10.2522/ptj.20090104.PubMedCrossRefGoogle Scholar
  58. 58.
    Cheville AL, Tchou J. Barriers to rehabilitation following surgery for primary breast cancer. J Surg Oncol. 2007;95(5):409–18.  https://doi.org/10.1002/jso.20782.PubMedCrossRefGoogle Scholar
  59. 59.
    Borstad JD. Resting position variables at the shoulder: evidence to support a posture-impairment association. Phys Ther. 2006;86(4):549–57.PubMedGoogle Scholar
  60. 60.
    Levangie PK, Drouin J. Magnitude of late effects of breast cancer treatments on shoulder function: a systematic review. Breast Cancer Res Treat. 2008;116(1):1–15.  https://doi.org/10.1007/s10549-008-0246-4.PubMedCrossRefGoogle Scholar
  61. 61.
    Harrington S, Padua D, Battaglini C, et al. Comparison of shoulder flexibility, strength, and function between breast cancer survivors and healthy participants. J Cancer Surviv. 2011;5(2):167–74.  https://doi.org/10.1007/s11764-010-0168-0.PubMedCrossRefGoogle Scholar
  62. 62.
    Uppal HS. Frozen shoulder: a systematic review of therapeutic options. World J Orthod. 2015;6(2):263–7.  https://doi.org/10.5312/wjo.v6.i2.263.CrossRefGoogle Scholar
  63. 63.
    Jeong HJ, Sim Y-J, Hwang KH, Kim GC. Causes of shoulder pain in women with breast cancer-related lymphedema: a pilot study. Yonsei Med J. 2011;52(4):661–7.  https://doi.org/10.3349/ymj.2011.52.4.661.PubMedPubMedCentralCrossRefGoogle Scholar
  64. 64.
    Leonidou A, Woods DA. A preliminary study of manipulation under anaesthesia for secondary frozen shoulder following breast cancer treatment. Ann R Coll Surg Engl. 2014;96(2):111–5.  https://doi.org/10.1308/003588414X13824511649652.PubMedPubMedCentralCrossRefGoogle Scholar
  65. 65.
    Stubblefield MD, Custodio CM. Upper-extremity pain disorders in breast cancer. Arch Phys Med Rehabil. 2006;87(3 Suppl 1):S96–9; quiz S100-1.  https://doi.org/10.1016/j.apmr.2005.12.017.PubMedCrossRefGoogle Scholar
  66. 66.
    Leidenius M, Leivonen M, Vironen J, Smitten von K. The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance. J Surg Oncol. 2005;92(1):23–31.  https://doi.org/10.1002/jso.20373.PubMedCrossRefGoogle Scholar
  67. 67.
    Yang S, Park DH, Ahn SH, et al. Prevalence and risk factors of adhesive capsulitis of the shoulder after breast cancer treatment. Support Care Cancer. 2017;25(4):1317–22.  https://doi.org/10.1007/s00520-016-3532-4.PubMedCrossRefGoogle Scholar
  68. 68.
    Hopwood P, Haviland JS, Sumo G, et al. Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials. Lancet Oncol. 2010;11(3):231–40.  https://doi.org/10.1016/S1470-2045(09)70382-1.PubMedCrossRefGoogle Scholar
  69. 69.
    Conduah AH, Baker CL, Baker CL. Clinical management of scapulothoracic bursitis and the snapping scapula. Sports Health. 2010;2(2):147–55.  https://doi.org/10.1177/1941738109338359.PubMedPubMedCentralCrossRefGoogle Scholar
  70. 70.
    Boneti C, Arentz C, Klimberg VS. Scapulothoracic bursitis as a significant cause of breast and chest wall pain: underrecognized and undertreated. Ann Surg Oncol. 2010;17(S3):321–4.  https://doi.org/10.1245/s10434-010-1232-8.PubMedCrossRefGoogle Scholar
  71. 71.
    Straub JM, New J, Hamilton CD, Lominska C, Shnayder Y, Thomas SM. Radiation-induced fibrosis: mechanisms and implications for therapy. J Cancer Res Clin Oncol. 2015;141(11):1–10.  https://doi.org/10.1007/s00432-015-1974-6.CrossRefGoogle Scholar
  72. 72.
    van Geel AN, Lans TE, Haen R, Tjong Joe Wai R, Menke-Pluijmers MBE. Partial mastectomy and m. latissimus dorsi reconstruction for radiation-induced fibrosis after breast-conserving cancer therapy. World J Surg. 2011;35(3):568–72.  https://doi.org/10.1007/s00268-010-0911-8.PubMedCrossRefGoogle Scholar
  73. 73.
    Liss AL, Ben-David MA, Jagsi R, et al. Decline of cosmetic outcomes following accelerated partial breast irradiation using intensity modulated radiation therapy: results of a single-institution prospective clinical trial. Int J Radiat Oncol Biol Phys. 2014;89(1):96–102.  https://doi.org/10.1016/j.ijrobp.2014.01.005.PubMedPubMedCentralCrossRefGoogle Scholar
  74. 74.
    Bourgier C, Acevedo-Henao C, Dunant A, et al. Higher toxicity with 42 Gy in 10 fractions as a total dose for 3D-conformal accelerated partial breast irradiation: results from a dose escalation phase II trial. Radiat Oncol. 2012;7(1):141.  https://doi.org/10.1186/1748-717X-7-141.PubMedPubMedCentralCrossRefGoogle Scholar
  75. 75.
    Edvardsen H, Tefre T, Jansen L, et al. Linkage disequilibrium pattern of the ATM gene in breast cancer patients and controls; association of SNPs and haplotypes to radio-sensitivity and post-lumpectomy local recurrence. Radiat Oncol. 2007;2(1):25–9.  https://doi.org/10.1186/1748-717X-2-25.PubMedPubMedCentralCrossRefGoogle Scholar
  76. 76.
    Chen PY, Vicini FA, Benitez P, et al. Long-term cosmetic results and toxicity after accelerated partial-breast irradiation. Cancer. 2006;106(5):991–9.  https://doi.org/10.1002/cncr.21681.PubMedCrossRefGoogle Scholar
  77. 77.
    Jacobson G, Bhatia S, Smith BJ, Button AM, Bodeker K, Buatti J. Randomized trial of pentoxifylline and vitamin E vs standard follow-up after breast irradiation to prevent breast fibrosis, evaluated by tissue compliance meter. Int J Radiat Oncol Biol Phys. 2013;85(3):604–8.  https://doi.org/10.1016/j.ijrobp.2012.06.042.PubMedCrossRefGoogle Scholar
  78. 78.
    Bourgeois JF, Gourgou S, Kramar A. A randomized, prospective study using the LPG® technique in treating radiation-induced skin fibrosis: clinical and profilometric analysis. Skin Res Technol. 2008. doi: https://doi.org/10.1111/j.1600-0846.2007.00263.x.
  79. 79.
    Stubblefield MD, Levine A, Custodio CM, Fitzpatrick T. The role of botulinum toxin type A in the radiation fibrosis syndrome: a preliminary report. Arch Phys Med Rehabil. 2008;89(3):417–21.  https://doi.org/10.1016/j.apmr.2007.11.022.CrossRefGoogle Scholar
  80. 80.
    Headon H, Kasem A, Mokbel K. Capsular contracture after breast augmentation: an update for clinical practice. Arch Plast Surg. 2015;42(5):532–12.  https://doi.org/10.5999/aps.2015.42.5.532.PubMedPubMedCentralCrossRefGoogle Scholar
  81. 81.
    Adkinson JM, Miller NF, Murphy RX Jr. Neurectomy for breast reconstruction- related spasms of the pectoralis major muscle. Br J Plast Surg. 2014;67(2):257–9.  https://doi.org/10.1016/j.bjps.2013.06.025.CrossRefGoogle Scholar
  82. 82.
    O’Donnell CJ. Pectoral muscle spasms after mastectomy successfully treated with botulinum toxin injections. PMR. 2011;3(8):781–2.  https://doi.org/10.1016/j.pmrj.2011.02.023.CrossRefGoogle Scholar
  83. 83.
    Winfree CJ, Kline DG. Intraoperative positioning nerve injuries. Surg Neurol. 2005;63(1):5–18; discussion 18.  https://doi.org/10.1016/j.surneu.2004.03.024.PubMedCrossRefGoogle Scholar
  84. 84.
    Radhakrishnan K, Litchy WJ, O’Fallon WM, Kurland LT. Epidemiology of cervical radiculopathy. A population-based study from Rochester, Minnesota, 1976 through 1990. Brain. 1994;117(Pt 2):325–35.PubMedCrossRefGoogle Scholar
  85. 85.
    Ma H, Kim I. Horner syndrome associated with a herniated cervical disc: a case report. Korean J Spine. 2012;9(2):108–10.  https://doi.org/10.14245/kjs.2012.9.2.108.PubMedPubMedCentralCrossRefGoogle Scholar
  86. 86.
    Miller NR, Walsh FB, Hoyt WF. Walsh and Hoyt’s clinical neuro-ophthalmology. Philadelphia: Lippincott Williams & Wilkins; 2005.Google Scholar
  87. 87.
    Carozzi VA, Canta A, Chiorazzi A. Chemotherapy-induced peripheral neuropathy: what do we know about mechanisms? Neurosci Lett. 2015;596:90–107.  https://doi.org/10.1016/j.neulet.2014.10.014.PubMedCrossRefGoogle Scholar
  88. 88.
    Chaudhry V, Chaudhry M, Crawford TO, Simmons-O’Brien E, Griffin JW. Toxic neuropathy in patients with pre-existing neuropathy. Neurology. 2003;60(2):337–40.PubMedCrossRefGoogle Scholar
  89. 89.
    Albers JW, Chaudhry V, Cavaletti G, Donehower RC. Interventions for preventing neuropathy caused by cisplatin and related compounds. Albers JW, ed. Cochrane Database Syst Rev. 2014;3:CD005228.  https://doi.org/10.1002/14651858.CD005228.pub4.CrossRefGoogle Scholar
  90. 90.
    Piccolo J, Kolesar JM. Prevention and treatment of chemotherapy-induced peripheral neuropathy. Am J Health Syst Pharm. 2014;71(1):19–25.  https://doi.org/10.2146/ajhp130126.PubMedCrossRefGoogle Scholar
  91. 91.
    Verstappen CCP, Postma TJ, Geldof AA, Heimans JJ. Amifostine protects against chemotherapy-induced neurotoxicity: an in vitro investigation. Anticancer Res. 2004;24(4):2337–41.PubMedGoogle Scholar
  92. 92.
    Pachman DR, Barton DL, Watson JC, Loprinzi CL. Chemotherapy-induced peripheral neuropathy: prevention and treatment. Clin Pharmacol Ther. 2011;90(3):377–87.  https://doi.org/10.1038/clpt.2011.115.PubMedPubMedCentralCrossRefGoogle Scholar
  93. 93.
    Gamelin L, Boisdron-Celle M, Delva R, et al. Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-fluorouracil and leucovorin for advanced colorectal cancer. Clin Cancer Res. 2004;10(12 Pt 1):4055–61.  https://doi.org/10.1158/1078-0432.CCR-03-0666.PubMedCrossRefGoogle Scholar
  94. 94.
    Kottschade LA, Sloan JA, Mazurczak MA, et al. The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial. Support Care Cancer. 2011;19(11):1769–77.  https://doi.org/10.1007/s00520-010-1018-3.PubMedCrossRefGoogle Scholar
  95. 95.
    Amptoulach S, Tsavaris N. Neurotoxicity caused by the treatment with platinum analogues. Chemother Res Pract. 2011;2011(3):843019–5.  https://doi.org/10.1155/2011/843019.PubMedPubMedCentralCrossRefGoogle Scholar
  96. 96.
    Delanian S, Lefaix J-L, Pradat P-F. Radiation-induced neuropathy in cancer survivors. Radiother Oncol. 2012;105(3):273–82.  https://doi.org/10.1016/j.radonc.2012.10.012.PubMedPubMedCentralCrossRefGoogle Scholar
  97. 97.
    Burton CL, Chesterton LS, Chen Y, van der Windt DA. Clinical course and prognostic factors in conservatively managed carpal tunnel syndrome: a systematic review. Arch Phys Med Rehabil. 2015;97:836.  https://doi.org/10.1016/j.apmr.2015.09.013.PubMedCrossRefGoogle Scholar
  98. 98.
    Ganel A, Engel J, Sela M, Brooks M. Nerve entrapments associated with postmastectomy lymphedema. Cancer. 1979;44(6):2254–9.PubMedCrossRefGoogle Scholar
  99. 99.
    Hansen JT. Netter’s clinical anatomy. Philadelphia: Saunders; 2014.Google Scholar
  100. 100.
    Huisstede BM, Fridén J, Coert JH, Hoogvliet P, European HANDGUIDE Group. Carpal tunnel syndrome: hand surgeons, hand therapists, and physical medicine and rehabilitation physicians agree on a multidisciplinary treatment guideline – results from the European HANDGUIDE Study. Arch Phys Med Rehabil. 2014;95(12):2253–2263.  https://doi.org/10.1016/j.apmr.2014.06.022.PubMedCrossRefGoogle Scholar
  101. 101.
    Dirks J, Fredensborg BB, Christensen D, Fomsgaard JS, Flyger H, Dahl JB. A randomized study of the effects of single-dose gabapentin versus placebo on postoperative pain and morphine consumption after mastectomy. Anesthesiology. 2002;97(3):560–4.PubMedCrossRefGoogle Scholar
  102. 102.
    Björkman B, Arnér S, Hydén L-C. Phantom breast and other syndromes after mastectomy: eight breast cancer patients describe their experiences over time: a 2-year follow-up study. J Pain. 2008;9(11):1018–25.  https://doi.org/10.1016/j.jpain.2008.06.003.PubMedCrossRefGoogle Scholar
  103. 103.
    Ahmed A, Bhatnagar S, Rana SPS, Ahmad SM, Joshi S, Mishra S. Prevalence of phantom breast pain and sensation among postmastectomy patients suffering from breast cancer: a prospective study. Pain Pract. 2013;14(2):E17–28.  https://doi.org/10.1111/papr.12089.PubMedCrossRefGoogle Scholar
  104. 104.
    Polinsky ML. Functional status of long-term breast cancer survivors: demonstrating chronicity. Health Soc Work. 1994;19(3):165–73.PubMedCrossRefGoogle Scholar
  105. 105.
    Pohjolainen T. A clinical evaluation of stumps in lower limb amputees. Prosthetics Orthot Int. 1991;15(3):178–84.Google Scholar
  106. 106.
    Kak M, Nanda R, Ramsdale EE, Lukas RV. Treatment of leptomeningeal carcinomatosis: current challenges and future opportunities. J Clin Neurosci. 2015;22(4):632–7.  https://doi.org/10.1016/j.jocn.2014.10.022.PubMedPubMedCentralCrossRefGoogle Scholar
  107. 107.
    Niwińska A, Rudnicka H, Murawska M. Breast cancer leptomeningeal metastasis: the & nbsp; results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy. Clin Breast Cancer. 2015;15(1):66–72.  https://doi.org/10.1016/j.clbc.2014.07.004.PubMedCrossRefGoogle Scholar
  108. 108.
    Leal T, Chang JE, Mehta M, Robins HI. Leptomeningeal metastasis: challenges in diagnosis and treatment. Curr Cancer Ther Rev. 2011;7(4):319–27.  https://doi.org/10.2174/157339411797642597.PubMedPubMedCentralCrossRefGoogle Scholar
  109. 109.
    Papay FA, Verghese A, Stanton-Hicks M, Zins J. Complex regional pain syndrome of the breast in a patient after breast reduction. Ann Plast Surg. 1997;39(4):347–52.PubMedCrossRefGoogle Scholar
  110. 110.
    Graham LE, McGuigan C, Kerr S, Taggart AJ. Complex regional pain syndrome post mastectomy. Rheumatol Int. 2001;21(4):165–6.  https://doi.org/10.1007/s00296-001-0152-0.CrossRefGoogle Scholar
  111. 111.
    Khan F, Shaikh FM, Keane R, Conroy BP. Complex regional pain syndrome type I as a complication of axillary clearance. J Pain Symptom Manag. 2006;31(6):481–3.  https://doi.org/10.1016/j.jpainsymman.2006.02.003.CrossRefGoogle Scholar
  112. 112.
    Ashkar L, Omeroglu A, Halwani F, Alsharif S, Loutfi A, Mesurolle B. Post-traumatic neuroma following breast surgery. Breast J. 2013;19(6):671–2.  https://doi.org/10.1111/tbj.12186.PubMedCrossRefGoogle Scholar
  113. 113.
    Nguyen JT, Buchanan IA, Patel PP, Aljinovic N, Lee BT. Intercostal neuroma as a source of pain after aesthetic and reconstructive breast implant surgery. Br J Plast Surg. 2012;65(9):1199–203.  https://doi.org/10.1016/j.bjps.2012.04.003.CrossRefGoogle Scholar
  114. 114.
    Wong L. Intercostal neuromas: a treatable cause of postoperative breast surgery pain. Ann Plast Surg. 2001;46(5):481–4.PubMedCrossRefGoogle Scholar
  115. 115.
    Li Q, Gao E-L, Yang Y-L, Hu H-Y, Hu X-Q. Traumatic neuroma in a patient with breast cancer after mastectomy: a case report and review of the literature. World J Surg Oncol. 2012;10(1):35.  https://doi.org/10.1186/1477-7819-10-35.PubMedPubMedCentralCrossRefGoogle Scholar
  116. 116.
    Smith HS, Wu S-X. Persistent pain after breast cancer treatment. Ann Palliat Med. 2012;1(3):182–94.  https://doi.org/10.3978/j.issn.2224-5820.2012.10.13.PubMedCrossRefGoogle Scholar
  117. 117.
    Zuther JE, Norton S. Lymphedema management. New York: Thieme; 2012.Google Scholar
  118. 118.
    Russell NS, Floot B, van Werkhoven E, et al. Blood and lymphatic microvessel damage in irradiated human skin: the role of TGF-β, endoglin and macrophages. Radiother Oncol. 2015;116:455.  https://doi.org/10.1016/j.radonc.2015.08.024.PubMedCrossRefGoogle Scholar
  119. 119.
    Shao Y, Qi K, Zhou Q-H, Zhong D-S. Intermittent pneumatic compression pump for breast cancer-related lymphedema: a systematic review and meta-analysis of randomized controlled trials. Oncol Res Treat. 2014;37(4):170–4.  https://doi.org/10.1159/000360786.PubMedCrossRefGoogle Scholar
  120. 120.
    Moseley AL, Carati CJ, Piller NB. A systematic review of common conservative therapies for arm lymphoedema secondary to breast cancer treatment. Ann Oncol. 2007;18(4):639–46.  https://doi.org/10.1093/annonc/mdl182.PubMedCrossRefGoogle Scholar
  121. 121.
    E Lima MTBRM, E Lima JGM, de Andrade MFC, Bergmann A. Low-level laser therapy in secondary lymphedema after breast cancer: systematic review. Lasers Med Sci. 2014;29(3):1289–95.  https://doi.org/10.1007/s10103-012-1240-y.PubMedCrossRefGoogle Scholar
  122. 122.
    Mehrara BJ, Zampell JC, Suami H, Chang DW. Surgical management of lymphedema: past, present, and future. Lymphat Res Biol. 2011;9(3):159–67.  https://doi.org/10.1089/lrb.2011.0011.PubMedCrossRefGoogle Scholar
  123. 123.
    Travis EC, Shugg S, McEwan WM. Lymph node grafting in the treatment of upper limb lymphoedema: a clinical trial. ANZ J Surg. 2015;85(9):631–5.  https://doi.org/10.1111/ans.13171.PubMedCrossRefGoogle Scholar
  124. 124.
    Yeung WM, McPhail SM, Kuys SS. A systematic review of axillary web syndrome (AWS). J Cancer Surviv. 2015;9(4):576–98.  https://doi.org/10.1007/s11764-015-0435-1.PubMedCrossRefGoogle Scholar
  125. 125.
    Torres Lacomba M, Mayoral del Moral O, Coperias Zazo JL, Yuste Sánchez MJ, Ferrandez J-C, Zapico Goñi A. Axillary web syndrome after axillary dissection in breast cancer: a prospective study. Breast Cancer Res Treat. 2009;117(3):625–30.  https://doi.org/10.1007/s10549-009-0371-8.PubMedCrossRefGoogle Scholar
  126. 126.
    National Cancer Institute. Common terminology criteria for adverse events (CTCAE). NIH publication No. 09-5410. Bethesda: National Cancer Institute; 2010. Available at: https://www.eortc.be/services/doc/ctc/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf.
  127. 127.
    Chen M-F, Chen W-C, Lai C-H, Hung C-H, Liu K-C, Cheng Y-H. Predictive factors of radiation-induced skin toxicity in breast cancer patients. BMC Cancer. 2010;10(1):508–10.  https://doi.org/10.1186/1471-2407-10-508.PubMedPubMedCentralCrossRefGoogle Scholar
  128. 128.
    Hymes SR, Strom EA, Fife C. Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006. J Am Acad Dermatol. 2006;54(1):28–46.  https://doi.org/10.1016/j.jaad.2005.08.054.PubMedCrossRefGoogle Scholar
  129. 129.
    Harper JL, Franklin LE, Jenrette JM, Aguero EG. Skin toxicity during breast irradiation: pathophysiology and management. South Med J. 2004;97(10):989–93.  https://doi.org/10.1097/01.SMJ.0000140866.97278.87.PubMedCrossRefGoogle Scholar
  130. 130.
    Chan RJ, Webster J, Chung B, Marquart L, Ahmed M, Garantziotis S. Prevention and treatment of acute radiation-induced skin reactions: a systematic review and meta-analysis of randomized controlled trials. BMC Cancer. 2014;14(1):53.  https://doi.org/10.1186/1471-2407-14-53.PubMedPubMedCentralCrossRefGoogle Scholar
  131. 131.
    Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21(1):109–22.PubMedCrossRefGoogle Scholar
  132. 132.
    Jagsi R, Griffith KA, Boike TP, et al. Differences in the acute toxic effects of breast radiotherapy by fractionation schedule. JAMA Oncol. 2015;1(7):918–3.  https://doi.org/10.1001/jamaoncol.2015.2590.PubMedCrossRefGoogle Scholar
  133. 133.
    Shaitelman SF, Schlembach PJ, Arzu I, et al. Acute and short-term toxic effects of conventionally fractionated vs hypofractionated whole-breast irradiation. JAMA Oncol. 2015;1(7):931–11.  https://doi.org/10.1001/jamaoncol.2015.2666.PubMedPubMedCentralCrossRefGoogle Scholar
  134. 134.
    Kumar S, Juresic E, Barton M, Shafiq J. Management of skin toxicity during radiation therapy: a review of the evidence. J Med Imaging Radiat Oncol. 2010;54(3):264–79.  https://doi.org/10.1111/j.1754-9485.2010.02170.x.PubMedCrossRefGoogle Scholar
  135. 135.
    Cheville AL, Troxel AB, Basford JR, Kornblith AB. Prevalence and treatment patterns of physical impairments in patients with metastatic breast cancer. J Clin Oncol. 2008;26(16):2621–9.  https://doi.org/10.1200/JCO.2007.12.3075.PubMedPubMedCentralCrossRefGoogle Scholar
  136. 136.
    Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407:249–57.PubMedCrossRefGoogle Scholar
  137. 137.
    Maxwell L. Therapeutic ultrasound and tumour metastasis. Physiotherapy. 1995;81:272–5. https://doi.org/10.1016/S0031-9406(05)66822-8.CrossRefGoogle Scholar
  138. 138.
    Humble SR, Dalton AJ, Li L. A systematic review of therapeutic interventions to reduce acute and chronic post-surgical pain after amputation, thoracotomy or mastectomy. Eur J Pain. 2015;19(4):451–65.  https://doi.org/10.1002/ejp.567.PubMedCrossRefGoogle Scholar
  139. 139.
    Mahran E, Hassan ME. Comparison of pregabalin versus ketamine in postoperative pain management in breast cancer surgery. Saudi J Anaesth. 2015;9(3):253–7.  https://doi.org/10.4103/1658-354X.154697.PubMedPubMedCentralCrossRefGoogle Scholar
  140. 140.
    Kotlinska-Lemieszek A, Paulsen O, Kaasa S, Klepstad P. Polypharmacy in patients with advanced cancer and pain: a European cross-sectional study of 2282 patients. J Pain Symptom Manag. 2014;48(6):1145–59.  https://doi.org/10.1016/j.jpainsymman.2014.03.008.CrossRefGoogle Scholar
  141. 141.
    Portenoy RK, Ahmed E. Principles of opioid use in cancer pain. J Clin Oncol. 2014;32(16):1662–70.  https://doi.org/10.1200/JCO.2013.52.5188.PubMedCrossRefGoogle Scholar
  142. 142.
    Terkawi AS, Sharma S, Durieux ME, Thammishetti S, Brenin D, Tiouririne M. Perioperative lidocaine infusion reduces the incidence of post-mastectomy chronic pain: a double-blind, placebo-controlled randomized trial. Pain Physician. 2015;18(2):E139–46.PubMedGoogle Scholar
  143. 143.
    Fassoulaki A, Patris K, Sarantopoulos C, Hogan Q. The analgesic effect of gabapentin and mexiletine after breast surgery for cancer. Anesth Analg. 2002;95(4):985–91, table of contents.Google Scholar
  144. 144.
    Amr YM, Yousef AAA-M. Evaluation of efficacy of the perioperative administration of venlafaxine or gabapentin on acute and chronic postmastectomy pain. Clin J Pain. 2010;26(5):381–5.  https://doi.org/10.1097/AJP.0b013e3181cb406e.PubMedCrossRefGoogle Scholar
  145. 145.
    Fassoulaki A, Triga A, Melemeni A, Sarantopoulos C. Multimodal analgesia with gabapentin and local anesthetics prevents acute and chronic pain after breast surgery for cancer. Anesth Analg. 2005;101(5):1427–32.  https://doi.org/10.1213/01.ANE.0000180200.11626.8E.PubMedCrossRefGoogle Scholar
  146. 146.
    Liu L, Huang Q-M, Liu Q-G, et al. Effectiveness of dry needling for myofascial trigger points associated with neck and shoulder pain: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2015;96(5):944–55.  https://doi.org/10.1016/j.apmr.2014.12.015.PubMedCrossRefGoogle Scholar
  147. 147.
    Klç Z, Filiz MB, Çakr T, Toraman NF. Addition of suprascapular nerve block to a physical therapy program produces an extra benefit to adhesive capsulitis: a randomized controlled trial. Am J Phys Med Rehabil. 2015;94(10 Suppl 1):912–20.  https://doi.org/10.1097/PHM.0000000000000336.PubMedCrossRefGoogle Scholar
  148. 148.
    Ozkan K, Ozcekic AN, Sarar S, Cift H, Ozkan FU, Unay K. Suprascapular nerve block for the treatment of frozen shoulder. Saudi J Anaesth. 2012;6(1):52–5.  https://doi.org/10.4103/1658-354X.93061.PubMedPubMedCentralCrossRefGoogle Scholar
  149. 149.
    Favejee MM, Huisstede BMA, Koes BW. Frozen shoulder: the effectiveness of conservative and surgical interventions – systematic review. Br J Sports Med. 2010;45(1):49–56.  https://doi.org/10.1136/bjsm.2010.071431.PubMedCrossRefGoogle Scholar
  150. 150.
    Jones DS, Chattopadhyay C. Suprascapular nerve block for the treatment of frozen shoulder in primary care: a randomized trial. Br J Gen Pract. 1999;49(438):39–41.PubMedPubMedCentralGoogle Scholar
  151. 151.
    Dahan TH, Fortin L, Pelletier M, Petit M, Vadeboncoeur R, Suissa S. Double blind randomized clinical trial examining the efficacy of bupivacaine suprascapular nerve blocks in frozen shoulder. J Rheumatol. 2000;27(6):1464–9.PubMedGoogle Scholar
  152. 152.
    Blanco R, Parras T, McDonnell JG, Prats-Galino A. Serratus plane block: a novel ultrasound-guided thoracic wall nerve block. Anaesthesia. 2013;68(11):1107–13.  https://doi.org/10.1111/anae.12344.PubMedCrossRefGoogle Scholar
  153. 153.
    (null) NYSORA. Thoracic paravertebral block. http://www.nysora.com/techniques/neuraxial-and-perineuraxial-techniques/landmark-based/3077-thoracic-paravertebral-block.html. Published May 9, 2013. Accessed 8 Oct 2015.
  154. 154.
    Krediet AC, Moayeri N, van Geffen G-J, et al. Different approaches to ultrasound-guided thoracic paravertebral block: an illustrated review. Anesthesiology. 2015;123(2):459–74.  https://doi.org/10.1097/ALN.0000000000000747.PubMedCrossRefGoogle Scholar
  155. 155.
    Kairaluoma PM, Bachmann MS, Korpinen AK, Rosenberg PH, Pere PJ. Single-injection paravertebral block before general anesthesia enhances analgesia after breast cancer surgery with and without associated lymph node biopsy. Anesth Analg. 2004;99(6):1837–43, table of contents.  https://doi.org/10.1213/01.ANE.0000136775.15566.87.PubMedCrossRefGoogle Scholar
  156. 156.
    Kairaluoma PM, Bachmann MS, Rosenberg PH, Pere PJ. Preincisional paravertebral block reduces the prevalence of chronic pain after breast surgery. Anesth Analg. 2006;103(3):703–8.  https://doi.org/10.1213/01.ane.0000230603.92574.4e.PubMedCrossRefGoogle Scholar
  157. 157.
    Exadaktylos AK, Buggy DJ, Moriarty DC, Mascha E, Sessler DI. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology. 2006;105(4):660–4.PubMedPubMedCentralCrossRefGoogle Scholar
  158. 158.
    Kirvelä O, Antila H. Thoracic paravertebral block in chronic postoperative pain. Reg Anesth. 1992;17(6):348–50.PubMedGoogle Scholar
  159. 159.
    Yucel I, Demiraran Y, Ozturan K, Degirmenci E. Complex regional pain syndrome type I: efficacy of stellate ganglion blockade. J Orthop Traumatol. 2009;10(4):179–83.  https://doi.org/10.1007/s10195-009-0071-5.PubMedPubMedCentralCrossRefGoogle Scholar
  160. 160.
    Fishman S, Ballantyne J, Rathmell JP. Bonica’s management of pain. In: Diagnostic and therapeutic nerve blocks. Philadelphia: Lippincott Williams & Wilkins; 2010. p. 1661.Google Scholar
  161. 161.
    Hoseinzade H, Mahmoodpoor A, Agamohammadi D, Sanaie S. Comparing the effect of stellate ganglion block and gabapentin on the post mastectomy pain syndrome. Rawal Med J. 2008;33(1):22–5. http://www.scopemed.org/?mno=7389Google Scholar
  162. 162.
    Nabil Abbas D, Abd El Ghafar EM, Ibrahim WA, Omran AF. Fluoroscopic stellate ganglion block for postmastectomy pain: a comparison of the classic anterior approach and the oblique approach. Clin J Pain. 2011;27(3):207–13.  https://doi.org/10.1097/AJP.0b013e3181fb1ef1.PubMedPubMedCentralCrossRefGoogle Scholar
  163. 163.
    Park JH, Min Y-S, Chun SM, Seo KS. Effects of stellate ganglion block on breast cancer-related lymphedema: comparison of various injectates. Pain Physician. 2015;18(1):93–9.PubMedGoogle Scholar
  164. 164.
    New York School of Regional Anesthesia. Intercostal block. http://www.nysora.com/techniques/neuraxial-and-perineuraxial-techniques/landmark-based/3072-intercostal-block.html. Published March 9, 2013. Accessed 12 Oct 2015.
  165. 165.
    Ducic I, Larson EE. Outcomes of surgical treatment for chronic postoperative breast and abdominal pain attributed to the intercostal nerve. J Am Coll Surg. 2006;203(3):304–10.  https://doi.org/10.1016/j.jamcollsurg.2006.05.018.PubMedCrossRefGoogle Scholar
  166. 166.
    Cohen SP, Sireci A, Wu CL, Larkin TM, Williams KA, Hurley RW. Pulsed radiofrequency of the dorsal root ganglia is superior to pharmacotherapy or pulsed radiofrequency of the intercostal nerves in the treatment of chronic postsurgical thoracic pain. Pain Physician. 2006;9(3):227–35.PubMedGoogle Scholar
  167. 167.
    Blanco R. The “pecs block”: a novel technique for providing analgesia after breast surgery. Anaesthesia. 2011;66(9):847–8.  https://doi.org/10.1111/j.1365-2044.2011.06838.x.PubMedCrossRefGoogle Scholar
  168. 168.
    Blanco R, Fajardo M, Parras Maldonado T. Ultrasound description of Pecs II (modified Pecs I): a novel approach to breast surgery. Rev Esp Anestesiol Reanim. 2012;59(9):470–5.  https://doi.org/10.1016/j.redar.2012.07.003.PubMedCrossRefGoogle Scholar
  169. 169.
    Wahba SS, Kamal SM. Thoracic paravertebral block versus pectoral nerve block for analgesia after breast surgery. Egypt J Anaesth. 2014;30(2):129–35.  https://doi.org/10.1016/j.egja.2013.10.006.CrossRefGoogle Scholar
  170. 170.
    Hoefflin SM. Botox alternatives. Plast Reconstr Surg. 1998;101(3):865.PubMedGoogle Scholar
  171. 171.
    Lo KK, Aycock JK. A blinded randomized controlled trial to evaluate the use of botulinum toxin for pain control in breast reconstruction with tissue expanders. Ann Plast Surg. 2015;74(3):281–3.  https://doi.org/10.1097/SAP.0b013e31829be8d8.PubMedCrossRefGoogle Scholar
  172. 172.
    Perotto A, Delagi EF. Anatomical guide for the electromyographer. Springfield: Charles C Thomas Publisher; 2005.Google Scholar
  173. 173.
    Doretti A, Gerevini S, Riccardi B, Gregorini F, Silani V, Maderna L. Flash posters. Eur J Neurol. 2015;22(S1):484–828.  https://doi.org/10.1111/ene.12808.CrossRefGoogle Scholar
  174. 174.
    Senior MA, Fourie LR. Botox and the management of pectoral spasm after subpectoral implant insertion. Plast Reconstr Surg. 2000;106(1):224–5.PubMedCrossRefGoogle Scholar
  175. 175.
    Frey ME, Manchikanti L, Benyamin RM, Schultz DM, Smith HS, Cohen SP. Spinal cord stimulation for patients with failed back surgery syndrome: a systematic review. Pain Physician. 2009;12(2):379–97.PubMedGoogle Scholar
  176. 176.
    Yakovlev AE, Ellias Y. Spinal cord stimulation as a treatment option for intractable neuropathic cancer pain. Clin Med Res. 2008;6(3–4):103–6.  https://doi.org/10.3121/cmr.2008.813.PubMedPubMedCentralCrossRefGoogle Scholar
  177. 177.
    Peng L, Min S, Zejun Z, Wei K, Bennett MI. Spinal cord stimulation for cancer-related pain in adults. Min S, ed. Cochrane Database Syst Rev. 2015;6(6):CD009389.  https://doi.org/10.1002/14651858.CD009389.pub3.CrossRefGoogle Scholar
  178. 178.
    Knotkova H, Rasche D. Textbook of neuromodulation. New York: Springer; 2014.Google Scholar
  179. 179.
    Christo PJ, Mazloomdoost D. Interventional pain treatments for cancer pain. Ann N Y Acad Sci. 2008;1138(1):299–328.  https://doi.org/10.1196/annals.1414.034.PubMedCrossRefGoogle Scholar
  180. 180.
    Smith TJ, Staats PS, Deer T, et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol. 2002;20(19):4040–9.PubMedPubMedCentralCrossRefGoogle Scholar
  181. 181.
    Gulati A, Shah R, Puttanniah V, Hung JC, Malhotra V. A retrospective review and treatment paradigm of interventional therapies for patients suffering from intractable thoracic chest wall pain in the oncologic population. Pain Med. 2015;16(4):802–10.  https://doi.org/10.1111/pme.12558.PubMedCrossRefGoogle Scholar
  182. 182.
    Brogan SE, Winter NB, Abiodun A, Safarpour R. A cost utilization analysis of intrathecal therapy for refractory cancer pain: identifying factors associated with cost benefit. Pain Med. 2013;14(4):478–86.  https://doi.org/10.1111/pme.12060.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Ali Valimahomed
    • 1
  • Jennifer Zocca
    • 2
  • Amitabh Gulati
    • 3
  1. 1.Department of Physical Medicine and RehabilitationNew York-Presbyterian Hospital, Weill Cornell Medical College/Columbia University Vagelos College of Physicians and SurgeonsNew YorkUSA
  2. 2.Department of AnesthesiologyNew York-Presbyterian Hospital, Weill Cornell Medical CollegeNew YorkUSA
  3. 3.Department of Anesthesiology and Critical CareMemorial Sloan Kettering Cancer CenterNew YorkUSA

Personalised recommendations